Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label multicenter study of Jiuwei Zhenxin Granules for generalized anxiety disorder
ChiCTR1800020070Phase 4Completed
- Sponsor
- West China Medical Center
- Start
- Dec 2010
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of jiuwei zhenxin in generalized anxiety disorder (GAD) and mixed anxiety-depressive disorder, sponsored by West China Medical Center. Primary endpoints: HAMA total score, HAMA factor scores and 3 more. Started Dec 2010; status: completed.
02
Drugs
jiuwei zhenxin
03
Conditions
generalized anxiety disorder (GAD)mixed anxiety-depressive disorder
Beyond the preview
Go deeper on ChiCTR1800020070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020070.